SECTOR SNAPSHOT
Market transactions picked up in April. Ascendas REIT announced its acquisition of a remaining 75% stake in Galaxis, a business park in one-north for S$543.8mn. IREIT (IREIT SP, Accumulate, S$0.68) added 15.8% to its AUM through a sale-and-leaseback deal with Decathlon for 27 retail properties in France. Mapletree Industrial Trust’s (MIT SP, Not Rated) acquisition of 29 US data centres for S$1.8bn is expected to boost its AUM by 26.5%. Elsewhere, ESR REIT (EREIT SP, Not Rated) will acquire a S$124.7mn logistics facility in Singapore and a 10% stake in a GIC majority-owned Australian logistics fund for S$68.5mn – its first overseas investment.
Developers may tap the Singapore market through REIT IPOs in the next 12 months. Unlisted Mapletree Investments is exploring a US$1bn student housing REIT IPO while City Developments (CIT SP, Buy, S$10.68) is in talks with Qatar Investment Authority to inject HSBC’s London headquarters building into a planned sterling-denominated UK commercial REIT by City Developments. The potential deal could boost the REIT’s portfolio to £1.8bn (S$3.4bn) from £600mn.
Rising community cases in Singapore forced the government to tighten COVID-19 restrictions on 14 May 2021. The latest measures include cutting group sizes from five to two persons, a prohibition of in-restaurant dining and reinstatement of the work-from-home default. These new measures will take effect from 16 May to 13 June. While they will weigh on F&B operators, several REITs, as well as Enterprise Singapore, have pledged support for F&B tenants and operators. Enterprise Singapore will alleviate delivery charges by funding five percentage points of the commissions charged by the three food delivery platforms: Deliveroo, foodpanda and GrabFood. These platforms typically charge 30% commissions on orders. Frasers Centrepoint Trust (FCT SP, Buy, S$2.88) intends to support tenants through free delivery services and customer rewards, rental and operational assistance and extension of grace periods for all vehicles entering all its malls to support delivery riders and drivers. Mapletree Commercial Trust (MCT SP, Not Rated) will provide rental and operating assistance to its retail tenants. CapitaLand Integrated Commercial Trust’s (CICT SP, Buy, S$2.54) Westgate will be close for two weeks commencing 14 May due to the several COVID-19 infections linked to the mall. The REIT will extend rental waivers as well as platform and commission waivers for online sales made through the eCapitaMalls and Captia3Eat platform during the mall closure period.
The cancellation of the World Economic Forum in Singapore in August 2021 is a minor setback for the hospitality industry. It may result in a loss of confidence and reduction of corporate travellers and bookings. On the other hand, the increase in infection cases may require the government to maintain or increase the number of hotels used for block booking for quarantine purposes.
Office
Leasing for Singapore and US office REITs has picked up, a reversal from the past three quarters when tenants delayed decision-making. Renewals formed the bulk of the leases signed. Bank tenants were the main downsizers. Excluding them, most tenants have retained their previous space requirements. Occupancy for the majority of the office REITs dipped due to non-renewals. This mirrored the industry’s occupancy, which slid 0.1ppt QoQ to 88.1%.
Reversions were mostly positive, in keeping with a 3.3% QoQ improvement in the rental index. However, rents were still 4.8% lower YoY. Reversions for Keppel REIT (KREIT SP, Not Rated) were strong at 10.4%, owing to its under-rented portfolio. OUE Commercial REIT’s (OUECT SP,
Not Rated) reversions were 3.8-7.8%. CapitaLand Integrated Commercial Trust’s (CICT SP, Buy, S$2.54) office reversions were negative, weighed down by a renewal with a large tenant. Reversions for Prime US REIT (PRIME SP, Accumulate, US$0.94), Keppel Pacific Oak (KORE SP, Not Rated) and Manulife US REIT (MUST SP, Buy, US$0.84) came in at 9.5%, 5.7% and 2.5% respectively.
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
